CyTOF and multiplex cytokine profiling studies in NSCLC patients receiving anti-PD-1 therapy have shown that higher baseline frequencies of exhausted CD8+ T cells, particularly the CD8+CD101hiTIM3+ subset, correlate with poor therapeutic outcomes. Here, CD8A is linked to non-small cell lung carcinoma.